Showing results (111-120 of 126) with videos related to
Sort By:
Pageof 13
Journal of Applied Toxicology : JAT|August 3, 2010
Inter-laboratory validation of the modified murine local lymph node assay based on 5-bromo-2'-deoxyuridine incorporationHajime Kojima, Masahiro Takeyoshi, Takashi Sozu, et al.The Lancet. Neurology|September 14, 2010
Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trialYukito Shinohara, Yasuo Katayama, Shinichiro Uchiyama, et al.Cerebrovascular Diseases (Basel, Switzerland)|May 14, 2014
Benefit of cilostazol in patients with high risk of bleeding: subanalysis of cilostazol stroke prevention study 2Shinichiro Uchiyama, Yukito Shinohara, Yasuo Katayama, et al.Journal of Cardiology|September 12, 2015
Randomized controlled trial of TY-51924, a novel hydrophilic NHE inhibitor, in acute myocardial infarctionKazuo Kimura, Koichi Nakao, Yoshisato Shibata, et al.Alternatives to Laboratory Animals : ATLA|May 8, 2012
Validation study of the in vitro skin irritation test with the LabCyte EPI-MODEL24Hajime Kojima, Yoko Ando, Kenji Idehara, et al.International Journal of Clinical Oncology|January 13, 2017
Preplanned safety analysis of the JFMC37-0801 trial: a randomized phase III study of six months versus twelve months of capecitabine as adjuvant chemotherapy for stage III colon cancerTakeshi Suto, Megumi Ishiguro, Chikuma Hamada, et al.Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|October 18, 2015
Efficacy and safety of S-1 and oxaliplatin combination therapy in elderly patients with advanced gastric cancerHideaki Bando, Yasuhide Yamada, Satoshi Tanabe, et al.Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|November 9, 2016
Impact of progression type on overall survival in patients with advanced gastric cancer based on randomized phase III study of S-1 plus oxaliplatin versus S-1 plus cisplatinKazuhiro Nishikawa, Yasuhide Yamada, Kenji Ishido, et al.The Journal of Dermatology|February 19, 2013
Optimal patch application time in the evaluation of skin irritationHiromi Kanto, Kumiko Washizaki, Masatoshi Ito, et al.International Journal of Clinical Oncology|January 7, 2016
Meta-analysis supporting noninferiority of oxaliplatin plus S-1 to cisplatin plus S-1 in first-line treatment of advanced gastric cancer (G-SOX study): indirect comparison with S-1 aloneChikuma Hamada, Yasuhide Yamada, Mizutomo Azuma, et al.Pageof 13